Focus Partners Wealth’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Sell
5,220
-1,476
-22% -$681K ﹤0.01% 1209
2026
Q1
$3.22M Sell
6,696
-1,475
-18% -$755K ﹤0.01% 1108
2025
Q4
$4.59M Buy
8,171
+3,419
+72% +$1.94M 0.01% 976
2025
Q3
$2.44M Buy
4,752
+3,656
+334% +$1.6M ﹤0.01% 957
2025
Q2
$344K Sell
1,096
-358
-25% -$107K ﹤0.01% 1607
2025
Q1
$443K Sell
1,454
-878
-38% -$295K ﹤0.01% 1397
2024
Q4
$775K Buy
2,332
+1,536
+193% +$521K ﹤0.01% 1148
2024
Q3
$266K Buy
+796
New +$302K ﹤0.01% 1369

Other funds holding MEDP

Focus Partners Wealth's MEDP Position: Q2 2026 in Review

Focus Partners Wealth reduced its Medpace (MEDP) stake by 22% in Q2 2026, selling an estimated $681K and leaving 5,220 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Focus Partners Wealth first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.59M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Focus Partners Wealth held 5,220 shares of Medpace worth $2.76M as of Q2 2026.
  • Focus Partners Wealth sold 1,476 Medpace shares in Q2 2026, an estimated $681K.
  • Medpace made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1209 holding.
  • Focus Partners Wealth first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • Focus Partners Wealth's Medpace position peaked at $4.59M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.